News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hill-Rom, Inc. Announces 11 Percent Dividend Increase In Second Quarter 2014


3/7/2014 6:36:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BATESVILLE, Ind., March 7, 2014 /PRNewswire/ -- Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that its Board of Directors has increased the company's fiscal year 2014 second quarter dividend 11 percent to $0.1525 per share. This dividend is payable on March 31, 2014 to shareholders of record as of the close of business on March 20, 2014. This brings the annualized dividend rate per share to $0.61 from $0.55.

Hill-Rom Logo.

"We are pleased to increase our dividend 11 percent from the previous annualized rate and 22 percent from the quarterly rate just one year ago," said Jay Saccaro, Senior Vice President and Chief Financial Officer. "This increase is consistent with our commitment to enhancing shareholder value by returning a substantial portion of operating cash flow to our shareholders."

ABOUT HILL-ROM HOLDINGS, INC.

Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, surgical products and information technology solutions. Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum and around the world in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

Hill-Rom...enhancing outcomes for patients and their caregivers.

www.hill-rom.com

Logo - http://photos.prnewswire.com/prnh/20130123/DE47178LOGO

SOURCE Hill-Rom Holdings, Inc.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES